Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00781326 · ClinicalTrials.gov registry record · Phase 4
Effectiveness of Nimodipine Plus Antidepressant Medication in Treating Vascular Depression
A Phase 4 study, sponsored by University of Pittsburgh.
- Terminated
- Registry status
- Phase 4
- Development phase
- 9
- Enrollment target
NCT00781326: Clinical Trial Phase 4 study, sponsored by University of Pittsburgh.
NCT00781326 is a Phase 4 study that was terminated before completion, run by University of Pittsburgh. The registered enrollment target is 9 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00781326, a Phase 4 study, was terminated before completion, sponsored by University of Pittsburgh.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 9 participants
- Enrollment target
Study Summary
This study will examine whether combined use of an antidepressant medication and the medication nimodipine reduces risk of depression relapse in patients with vascular depression.
Primary Outcome
Hamilton Depression Rating Scale (24 item) measures symptoms of major depression. We report total score which is the sum of all items. Total score range is 0 to 76 with higher scores indicating more severe depression. We reports scores at end of Phase I for subjects completing the phase.
Interventions
- DRUG Placebo
- DRUG Nimodipine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2008-08 |
| Est. Completion | 2009-02 |
| Phase | Phase 4 |
Why NCT00781326 stopped before completion
NCT00781326 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00781326 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00781326 about?
NCT00781326 is a clinical study titled "Effectiveness of Nimodipine Plus Antidepressant Medication in Treating Vascular Depression". This study will examine whether combined use of an antidepressant medication and the medication nimodipine reduces risk of depression relapse in patients with vascular depression.
What is the current status of trial NCT00781326?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 9 participants. The study started on 2008-08. Estimated completion is 2009-02.
What interventions are being tested in trial NCT00781326?
The interventions under investigation include: Placebo (DRUG), Nimodipine (DRUG).
Who is sponsoring clinical trial NCT00781326?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00781326's enrollment target sits among peer trials
9 1968th of 2000 higher than 29 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia